vTv Therapeutics up after FDA lifts clinical hold on its oral diabetes treatment study
Tv Therapeutics (NASDAQ:VTVT) said on Monday that the U.S. FDA has lifted the clinical hold on cadisegliatin's clinical trial ...
Vtv Therapeutics Shares Halted as FDA Clinical Hold on Diabetes Treatment Lifted
Cadisegliatin, which was paused in the third phase of its CATT1 trial, is taken orally and is designed to target the liver specifically and aims to treat diabetes by improving blood sugar control. VTv ...
vTv Therapeutics says FDA has lifted clinical hold on cadisegliatin program
Tv Therapeutics (VTVT) announced that the United States Food and Drug Administration has lifted the clinical hold on the cadisegliatin ...
Yahoo Finance22d
Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
today announced that it will hold investor calls to discuss recent developments on its mRNA therapeutic vaccine programs.